Rayzel Shulman1, Fiona A Miller1, Therese A Stukel1, Denis Daneman1, Astrid Guttmann1. 1. Department of Pediatrics (Shulman, Daneman, Guttmann), The Hospital for Sick Children, University of Toronto; Institute of Health Policy, Management and Evaluation (Shulman, Miller, Stukel, Guttmann), University of Toronto; Institute for Clinical Evaluative Sciences (Shulman, Stukel, Guttmann); Toronto Health Economics and Technology Assessment (THETA) Collaborative (Miller), University of Toronto, Toronto, Ont.
Abstract
BACKGROUND: The Network of Ontario Pediatric Diabetes Programs was established in 2001 to provide access to specialized pediatric diabetes care. Universal funding for pediatric insulin pump therapy has been available in Ontario since 2006. The objective of this study was to describe the distribution of patients, resources and insulin pump use across centres within the network, now called the Ontario Paediatric Diabetes Network. METHODS: We conducted a cross-sectional survey in 2012 of the 35 pediatric diabetes centres in Ontario to measure centre characteristics, patient volume and available clinical and social resources. We used health administrative data from the provincial Assistive Devices Program to describe patients aged 18 years or less using insulin pumps by centre as a measure of technology uptake. RESULTS: All 35 centres participated, reporting a total of 6676 children with type 1 diabetes and 368 with type 2 diabetes. Most (> 80%) children with type 1 diabetes were followed at tertiary (n = 5) or large community (n = 14) centres. Nursing patient load was similar between centre types, but there was a large range across centres within any type. Overall, percent insulin pump use was 38.1% and varied widely across centres (5.3%-66.7%). Funded 24-hour support for pump users was available at 5 (36%) small community centres, 3 (19%) large community centres and 2 (40%) tertiary centres. INTERPRETATION: Our study showed differences in access to specialized and after-hours care for children with diabetes in Ontario. Pump use varied widely across centres. Further research is needed to assess the impact of these observed differences on quality of care and outcomes.
BACKGROUND: The Network of Ontario Pediatric Diabetes Programs was established in 2001 to provide access to specialized pediatric diabetes care. Universal funding for pediatric insulin pump therapy has been available in Ontario since 2006. The objective of this study was to describe the distribution of patients, resources and insulin pump use across centres within the network, now called the Ontario Paediatric Diabetes Network. METHODS: We conducted a cross-sectional survey in 2012 of the 35 pediatric diabetes centres in Ontario to measure centre characteristics, patient volume and available clinical and social resources. We used health administrative data from the provincial Assistive Devices Program to describe patients aged 18 years or less using insulin pumps by centre as a measure of technology uptake. RESULTS: All 35 centres participated, reporting a total of 6676 children with type 1 diabetes and 368 with type 2 diabetes. Most (> 80%) children with type 1 diabetes were followed at tertiary (n = 5) or large community (n = 14) centres. Nursing patient load was similar between centre types, but there was a large range across centres within any type. Overall, percent insulin pump use was 38.1% and varied widely across centres (5.3%-66.7%). Funded 24-hour support for pump users was available at 5 (36%) small community centres, 3 (19%) large community centres and 2 (40%) tertiary centres. INTERPRETATION: Our study showed differences in access to specialized and after-hours care for children with diabetes in Ontario. Pump use varied widely across centres. Further research is needed to assess the impact of these observed differences on quality of care and outcomes.
Authors: Janet Silverstein; Georgeanna Klingensmith; Kenneth Copeland; Leslie Plotnick; Francine Kaufman; Lori Laffel; Larry Deeb; Margaret Grey; Barbara Anderson; Lea Ann Holzmeister; Nathaniel Clark Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: K Doggen; N Debacker; D Beckers; K Casteels; M Coeckelberghs; L Dooms; H Dorchy; M Lebrethon; K Logghe; M Maes; G Massa; T Mouraux; R Rooman; G Thiry-Counson; S Van Aken; J Vanbesien; V Van Casteren Journal: Eur J Pediatr Date: 2012-08-09 Impact factor: 3.183
Authors: Charlotte Gosden; Julie A Edge; Richard I G Holt; June James; Bridget Turner; Peter Winocour; Chris Walton; Dinesh Nagi; Rhys Williams; Krystyna Matyka Journal: Arch Dis Child Date: 2010-07-06 Impact factor: 3.791
Authors: Carine E de Beaufort; Karin Lange; Peter G F Swift; Jan Aman; Fergus Cameron; Luis Castano; Harry Dorchy; Lynda K Fisher; Hilary Hoey; Eero Kaprio; Mirjana Kocova; Andreas Neu; Pal R Njolstad; Moshe Phillip; Eugen Schoenle; Jean J Robert; Tatsuhiko Urukami; Maurizio Vanelli; Thomas Danne; Tim Barrett; Franco Chiarelli; Henk J Aanstoot; Henrik B Mortensen Journal: Pediatr Diabetes Date: 2012-09-10 Impact factor: 4.866
Authors: Joachim Rosenbauer; Axel Dost; Beate Karges; Andreas Hungele; Anna Stahl; Christina Bächle; Eva Maria Gerstl; Christian Kastendieck; Sabine E Hofer; Reinhard W Holl Journal: Diabetes Care Date: 2011-11-10 Impact factor: 19.112
Authors: Rayzel Shulman; Morgan Slater; Shahriar Khan; Carmen Jones; Jennifer D Walker; Kristen Jacklin; Michael E Green; Eliot Frymire; Baiju R Shah Journal: CMAJ Open Date: 2020-01-28
Authors: Rayzel Shulman; Ian Zenlea; Baiju R Shah; Cheril Clarson; Jennifer Harrington; Alanna Landry; Zubin Punthakee; Mark R Palmert; Geetha Mukerji; Peter C Austin; Janet Parsons; Noah Ivers Journal: BMC Health Serv Res Date: 2019-11-25 Impact factor: 2.655